Veterinary Vaccines Market Overview

An overview of conceptual frameworks, analytical approaches of the Veterinary Vaccines market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Veterinary Vaccines market is expected to grow with significant rate in the near future.

The global Veterinary Vaccines Market in 2020 is estimated for more than US$ 8.3 Bn and expected to reach a value of US$ 14.2 Bn by 2028 with a significant CAGR of 7.1%.

Veterinary Vaccines Market Definition

Veterinary vaccines are essentially important with regard to animal health care, the growth in the veterinary vaccines market is primarily attributed to augmented public awareness, research and development, and technological advancement, in particular, DNA-related vaccines.

Veterinary Vaccines Market Dynamics

Collaboration towards animal and human health for protection of both against zoonotic diseases, innovation towards pet health, and increasing vulnerability to the diseases such as bird flu, avian influenza, anthrax, and other viral and bacterial infections are some of the factors that will drive the growth of veterinary vaccines market during the forecast period.

Veterinary Vaccines Market Segmentation

The veterinary vaccines market is segmented on the basis of product type, disease type, end user, and by region

By Product Type

•    Subunit Recombinant Vaccines

•    Attenuated Vaccines

•    Vector Recombinant Vaccines

By Type

•    Porcine Vaccines

•    Poultry Vaccine

•    Livestock Vaccine

o    Bovine Vaccines

o    Small Ruminant Vaccines

•    Companion Animal Vaccine

o    Canine Vaccine

o    Feline Vaccine

•    Aquaculture Vaccines

•    Other Animal Vaccines

By Disease

•    Porcine

•    Poultry

•    Livestock

o    Bovine

o    Small Ruminant

•    Companion Animal

o    Canine

o    Feline

•    Aquaculture

By Technology

•    Live Attenuated Vaccines

•    Inactivated Vaccines

•    Toxoid Vaccines

•    Recombinant Vaccines

•    Other Vaccines

In 2019, vector recombinant vaccines product type segment is accounted to have the largest market share in terms of value and expected to remain to dominate throughout the forecast period (2020-2028).

According to Meridian Market Consultants analysis, in 2019, North America region is accounted for the largest market share in the veterinary vaccines market followed by Europe and expected to maintain its dominance throughout the forecasting period.

On the basis of disease type, infectious disease segment is accounted for the largest market share followed by cancer and allergies. In 2019, the infectious disease segment contributes more than 65% of veterinary vaccines market. On the basis of technology segment, the recombinant human vaccines segment is expected to dominate the market throughout the forecast period.

Veterinary Vaccines Market Key Players

Some of the key participating players in the veterinary vaccines market are:

•    Bayer HealthCare AG

•    Biogenesis-Bago

•    Boehringer Ingelheim GmbH

•    Heska Corporation

•    Imugen, Limited

•    Indian Immunologicals Ltd.

•    Lohmann Animal Health

•    Merck Animal Health, Merial Ltd.

•    Pfizer Inc.

•    Fort Dodge Animal Health

•    Protein Sciences Corporation

•    Virbac Corporation

Veterinary Vaccines Market Regional Segmentation Overview

On the basis of region, the veterinary vaccines market is segmented into six regions namely:

North America

Latin America

Asia Pacific

Europe

Middle East

Africa

North America veterinary vaccines market is expected to be the most dominating market throughout the forecast period.

MMC Overview on Veterinary Vaccines Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Veterinary Vaccines market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Veterinary Vaccines Market: Opportunity Analysis and Future Assessment 2020-2028’.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Veterinary Vaccines

•    Advantage of Veterinary Vaccines

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Veterinary Vaccines Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Veterinary Vaccines Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Veterinary Vaccines Market Snapshot

2.4.    Global Veterinary Vaccines Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Veterinary Vaccines Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Veterinary Vaccines Market, By Product Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product Type

3.1.2.    BPS Analysis, By Product Type

3.2.    Market Revenue (US$Mn) Forecast, By Product Type

3.2.1.    Subunit Recombinant Vaccines

3.2.2.    Attenuated Vaccines

3.2.3.    Vector Recombinant Vaccines

3.3.    Global Veterinary Vaccines Market Attractiveness Index, By Product Type

4.    Global Veterinary Vaccines Market, By End User

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By End User

4.1.2.    BPS Analysis, By End User

4.2.    Market Revenue (US$Mn) Forecast, By End User

4.2.1.    Commercial

4.2.2.    Residential

4.2.3.    Utility

4.3.    Global Veterinary Vaccines Market Attractiveness Index, By End User

5.    Global Veterinary Vaccines Market, By Diseases

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Diseases

5.1.2.    BPS Analysis, By Diseases

5.2.    Market Revenue (US$Mn) Forecast, By Diseases

5.2.1.    Infectious Disease

5.2.2.    Cancer

5.2.3.    Allergies

5.2.4.    Others

5.3.    Global Veterinary Vaccines Market Attractiveness Index, By Diseases

6.    Global Veterinary Vaccines Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Veterinary Vaccines Market Attractiveness Index, By Region

7.    North America Veterinary Vaccines Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Veterinary Vaccines Market

7.2.2.    Canada Veterinary Vaccines Market

7.3.    North America Veterinary Vaccines Market, By Product Type

7.3.1.    Cadmium Telluride (Cdte)

7.3.2.    Copper Indium Gallium Diselenide (CIGS)

7.3.3.    Amorphous Thin-Film Silicon

7.4.    North America Veterinary Vaccines Market, By Disease

7.4.1.    Infectious disease

7.4.2.    Cancer

7.4.3.    Allergies

7.4.4.    Others

7.5.    North America Veterinary Vaccines Market, By End User

7.5.1.    Recombinant Human Vaccines

7.5.2.    Animal Vaccines

7.5.2.1.    Poultry

7.5.2.2.    Companion Animal Vaccines

7.5.2.3.    Livestock

7.5.2.4.    Porcine

7.5.2.5.    Aquaculture Vaccines

7.6.    North America Veterinary Vaccines Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Product Type

7.6.3.    By Disease

7.6.4.    By End User

8.    Latin America Veterinary Vaccines Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Veterinary Vaccines Market

8.2.2.    Mexico Veterinary Vaccines Market

8.2.3.    Argentina Veterinary Vaccines Market

8.2.4.    Rest of Latin America Veterinary Vaccines Market

8.3.    Latin America Veterinary Vaccines Market, By Product Type

8.3.1.    Cadmium Telluride (Cdte)

8.3.2.    Copper Indium Gallium Diselenide (CIGS)

8.3.3.    Amorphous Thin-Film Silicon

8.4.    Latin America Veterinary Vaccines Market, By Disease

8.4.1.    Infectious disease

8.4.2.    Cancer

8.4.3.    Allergies

8.4.4.    Others

8.5.    Latin America Veterinary Vaccines Market, By End User

8.5.1.    Recombinant Human Vaccines

8.5.2.    Animal Vaccines

8.5.2.1.    Poultry

8.5.2.2.    Companion Animal Vaccines

8.5.2.3.    Livestock

8.5.2.4.    Porcine

8.5.2.5.    Aquaculture Vaccines

8.6.    Latin America Veterinary Vaccines Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Product Type

8.6.3.    By Disease

8.6.4.    By End User

9.    Europe Veterinary Vaccines Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Veterinary Vaccines Market

9.2.2.    Germany Veterinary Vaccines Market

9.2.3.    Italy Veterinary Vaccines Market

9.2.4.    France Veterinary Vaccines Market

9.2.5.    Spain Veterinary Vaccines Market

9.2.6.    Russia Veterinary Vaccines Market

9.2.7.    Poland Veterinary Vaccines Market

9.2.8.    BENELUX Veterinary Vaccines Market

9.2.9.    NORDIC Veterinary Vaccines Market

9.2.10.    Rest of Europe Veterinary Vaccines Market

9.3.    Europe Veterinary Vaccines Market, By Product Type

9.3.1.    Cadmium Telluride (Cdte)

9.3.2.    Copper Indium Gallium Diselenide (CIGS)

9.3.3.    Amorphous Thin-Film Silicon

9.4.    Europe Veterinary Vaccines Market, By Disease

9.4.1.    Infectious disease

9.4.2.    Cancer

9.4.3.    Allergies

9.4.4.    Others

9.5.    Europe Veterinary Vaccines Market, By End User

9.5.1.    Recombinant Human Vaccines

9.5.2.    Animal Vaccines

9.5.2.1.    Poultry

9.5.2.2.    Companion Animal Vaccines

9.5.2.3.    Livestock

9.5.2.4.    Porcine

9.5.2.5.    Aquaculture Vaccines

9.6.    Europe Veterinary Vaccines Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Product Type

9.6.3.    By Disease

9.6.4.    By End User

10.    Asia Pacific Veterinary Vaccines Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Veterinary Vaccines Market

10.2.2.    India Veterinary Vaccines Market

10.2.3.    Japan Veterinary Vaccines Market

10.2.4.    Australia and New Zealand Veterinary Vaccines Market

10.2.5.    South Korea Veterinary Vaccines Market

10.2.6.    ASEAN Veterinary Vaccines Market

10.2.7.    Rest of Asia Pacific Veterinary Vaccines Market

10.3.    Asia Pacific Veterinary Vaccines Market, By Product Type

10.3.1.    Cadmium Telluride (Cdte)

10.3.2.    Copper Indium Gallium Diselenide (CIGS)

10.3.3.    Amorphous Thin-Film Silicon

10.4.    Asia Pacific Veterinary Vaccines Market, By Disease

10.4.1.    Infectious disease

10.4.2.    Cancer

10.4.3.    Allergies

10.4.4.    Others

10.5.    Asia Pacific Veterinary Vaccines Market, By End User

10.5.1.    Recombinant Human Vaccines

10.5.2.    Animal Vaccines

10.5.2.1.    Poultry

10.5.2.2.    Companion Animal Vaccines

10.5.2.3.    Livestock

10.5.2.4.    Porcine

10.5.2.5.    Aquaculture Vaccines

10.6.    Asia Pacific Veterinary Vaccines Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Product Type

10.6.3.    By Disease

10.6.4.    By End User

11.    Middle East Veterinary Vaccines Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Veterinary Vaccines Market

11.2.2.    Israel Veterinary Vaccines Market

11.2.3.    Oman Veterinary Vaccines Market

11.2.4.    Rest of Middle East Veterinary Vaccines Market

11.3.    Middle East Veterinary Vaccines Market, By Product Type

11.3.1.    Cadmium Telluride (Cdte)

11.3.2.    Copper Indium Gallium Diselenide (CIGS)

11.3.3.    Amorphous Thin-Film Silicon

11.4.    Middle East Veterinary Vaccines Market, By Disease

11.4.1.    Infectious disease

11.4.2.    Cancer

11.4.3.    Allergies

11.4.4.    Others

11.5.    Middle East Veterinary Vaccines Market, By End User

11.5.1.    Recombinant Human Vaccines

11.5.2.    Animal Vaccines

11.5.2.1.    Poultry

11.5.2.2.    Companion Animal Vaccines

11.5.2.3.    Livestock

11.5.2.4.    Porcine

11.5.2.5.    Aquaculture Vaccines

11.6.    Middle East Veterinary Vaccines Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Product Type

11.6.3.    By Disease

11.6.4.    By End User

12.    Africa Veterinary Vaccines Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Veterinary Vaccines Market

12.2.2.    Egypt Veterinary Vaccines Market

12.2.3.    North Africa Veterinary Vaccines Market

12.2.4.    Rest of Africa Veterinary Vaccines Market

12.3.    Africa Veterinary Vaccines Market, By Product Type

12.3.1.    Cadmium Telluride (Cdte)

12.3.2.    Copper Indium Gallium Diselenide (CIGS)

12.3.3.    Amorphous Thin-Film Silicon

12.4.    Africa Veterinary Vaccines Market, By Disease

12.4.1.    Infectious disease

12.4.2.    Cancer

12.4.3.    Allergies

12.4.4.    Others

12.5.    Africa Veterinary Vaccines Market, By End User

12.5.1.    Recombinant Human Vaccines

12.5.2.    Animal Vaccines

12.5.2.1.    Poultry

12.5.2.2.    Companion Animal Vaccines

12.5.2.3.    Livestock

12.5.2.4.    Porcine

12.5.2.5.    Aquaculture Vaccines

12.6.    Africa Veterinary Vaccines Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Product Type

12.6.3.    By Disease

12.6.4.    By End User

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Bayer HealthCare AG

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Product Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Biogenesis-Bago

14.3.3.    Boehringer Ingelheim GmbH

14.3.4.    Heska Corporation

14.3.5.    Imugen, Limited

14.3.6.    Indian Immunologicals Ltd

14.3.7.    Lohmann Animal Health

14.3.8.    Merck Animal Health

14.3.9.    Merial Ltd.

14.3.10.    Pfizer Inc.

14.3.11.    Fort Dodge Animal Health

14.3.12.    Protein Sciences Corporation

14.3.13.    Virbac Corporation

15.    Acronyms